AUSTRALIAN Public Assessment Reports (AusPARs) have been generated for AstraZeneca's new chemical entity Zurampic (lesinurad) an adjunctive therapy for gout, Novartis' sacubitril/valsartan salt complex chronic heart failure treatment and Roche Products' Actemra, an adjunctive therapy for rheumatoid arthritis.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 17 Oct 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Oct 16
PHARMACY owners operating in regional cities need access to a Workforce Incentive Program (WIP) rather than $3,000 from the Rural Pharmacy Maintenance Allowance (RPMA), the Rural Pharmacy Network Australia (RPNA) believes.
FREE in-pharmacy health checks conducted using SiSU Health Stations are providing a deeper insight into the health of Australians, Priceline Pharmacy General Manager, Andrew Vidler, believes.
PHARMACY owners in Far North Queensland are showing their support for the expansion of James Cook University’s (JCU’s) pharmacy program to its Cairns and Mackay campuses, by funding an advertising campaign for the course.
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.